300482 万孚生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.544-1.14911.15411.00731.105
总资产报酬率 ROA (%)1.266-0.9168.6908.07821.458
投入资产回报率 ROIC (%)1.354-1.0129.7459.13925.310

边际利润分析
销售毛利率 (%)63.24356.97564.14562.61151.824
营业利润率 (%)16.832-5.29120.77919.86124.078
息税前利润/营业总收入 (%)19.867-3.49820.61119.32624.009
净利润/营业总收入 (%)14.804-3.33818.44217.62920.951

收益指标分析
经营活动净收益/利润总额(%)92.379141.888100.22086.96398.971
价值变动净收益/利润总额(%)10.172-46.5825.0108.4885.319
营业外收支净额/利润总额(%)-0.7613.729-1.173-1.549-0.235

偿债能力分析
流动比率 (X)3.2233.1784.6096.6772.936
速动比率 (X)2.9672.9084.1715.9522.586
资产负债率 (%)17.17117.08821.02620.04827.988
带息债务/全部投入资本 (%)10.87010.9409.66611.76218.144
股东权益/带息债务 (%)807.676800.848916.117730.796441.986
股东权益/负债合计 (%)477.120479.970369.218390.286246.313
利息保障倍数 (X)6.282-1.750284.607-83.428-1,954.013

营运能力分析
应收账款周转天数 (天)119.500162.994100.64874.11032.907
存货周转天数 (天)116.717128.334116.457130.82851.713